Cite
APA Citation
Caffo, O., Veccia, A., Maines, F., Bonetta, A., Spizzo, G., & Galligioni, E. (2014). potential value of rapid prostate-specific antigen decline in identifying primary resistance to abiraterone acetate and enzalutamide. Future oncology, 10, 985–993. http://access.bl.uk/ark:/81055/vdc_100144481611.0x000015